Clinical Trial: A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07628855) titled 'A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma' on June 01.

Brief Summary: This study is a randomized, open-label, multi-center phase II trial evaluating the efficacy and safety of the becotatug vedotin in combination with pucotenlimab regimen in patients with advanced head and neck squamous cell carcinoma who are intolerant to platinum-based therapy.

Study Start Date: May 14

Study Type: INTERVENTIONAL

Condition: HNPCC

Intervention: DRUG: Becotatug Vedotin (...